百傲化学(603360) - 2022 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2022 was CNY 294,068,308.89, representing a year-on-year increase of 34.65%[2] - The net profit attributable to shareholders was CNY 98,465,601.61, reflecting an increase of 89.97% compared to the same period last year[2] - Basic earnings per share were CNY 0.39, marking a 95.00% increase from the previous year[2] - The net profit after deducting non-recurring gains and losses was CNY 97,622,683.95, up 92.41% year-on-year[2] - The net profit for Q1 2022 was CNY 98,465,601.61, representing a 90% increase compared to CNY 51,831,316.56 in Q1 2021[18] - Operating profit for Q1 2022 reached CNY 117,161,373.68, up from CNY 61,054,786.14 in the same period last year, indicating a growth of approximately 92%[18] - The total comprehensive income for Q1 2022 was CNY 98,464,327.84, compared to CNY 51,831,316.56 in Q1 2021, indicating a substantial increase[19] Cash Flow - The net cash flow from operating activities reached CNY 115,713,254.47, up by 146.95% year-on-year[2] - Cash flow from operating activities for Q1 2022 was CNY 115,935,294.28, significantly higher than CNY 57,526,819.63 in Q1 2021, indicating a 101% increase[30] - The company reported a cash and cash equivalents balance of CNY 174,333,494.91 at the end of Q1 2022, compared to CNY 165,194,669.93 at the end of Q1 2021[23] - The cash and cash equivalents decreased by $36,487,878.77 during the period, compared to a decrease of $14,104,752.16 in the prior period[31] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,843,367,714.24, a 10.33% increase from the end of the previous year[3] - Total assets reached RMB 1,843,367,714.24 as of March 31, 2022, compared to RMB 1,670,722,296.11 at the end of 2021, marking a growth of 10.3%[14] - Total liabilities as of March 31, 2022, were RMB 692,945,164.29, up from RMB 621,067,170.25 at the end of 2021, reflecting an increase of 11.6%[13] - The company's total liabilities decreased to CNY 529,547,694.94 in Q1 2022 from CNY 551,951,327.46 in Q1 2021, a reduction of about 4%[26] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 15,026[6] - Major shareholder Dalian Tongyun Investment Co., Ltd. held 29.50% of the shares, with 38,800,000 shares pledged[7] Research and Development - Research and development expenses in Q1 2022 amounted to RMB 14,891,195.96, significantly higher than RMB 6,142,918.54 in Q1 2021, indicating a 142.5% increase[17] - Research and development expenses increased significantly to CNY 14,390,713.41, up from CNY 5,612,029.90 in the previous year, marking a 156% rise[28] Operating Costs - Total operating costs for Q1 2022 were RMB 178,026,084.85, up from RMB 151,813,050.45 in Q1 2021, reflecting a year-over-year increase of 17.4%[17] - The company's operating expenses, including sales and management costs, totaled CNY 39,073,204.35 in Q1 2022, compared to CNY 20,756,356.47 in Q1 2021, reflecting an increase of 88%[28] Financial Position - The weighted average return on equity increased by 3.69 percentage points to 8.96%[2] - The total equity of the company as of Q1 2022 was CNY 1,241,084,742.59, compared to CNY 1,133,201,098.34 in Q1 2021, showing an increase of approximately 10%[26] Investment Activities - Investment activities resulted in a net cash outflow of CNY 86,736,221.83 in Q1 2022, compared to a net outflow of CNY 77,700,663.70 in Q1 2021[22] - The cash outflow related to investment activities was $87,365,672.82, compared to $99,325,373.33 in the previous period[31]